Sd. Hanes et al., INCIDENCE AND RISK-FACTORS OF THROMBOCYTOPENIA IN CRITICALLY ILL TRAUMA PATIENTS, The Annals of pharmacotherapy, 31(3), 1997, pp. 285-289
OBJECTIVE: To determine the incidence of thrombocytopenia (<100 platel
ets x 10(3)/mm(3)) and potential risk factors, including medications,
associated with the development of thrombocytopenia in critically iu t
rauma patients. DESIGN: Prospective, observational study. SETTING: A 2
0-bed trauma intensive care unit (ICU) at a university hospital. PATIE
NTS: Sixty-three critically ill trauma patients without baseline throm
bocytopenia admitted to the trauma ICU for at least 48 hours. INTERVEN
TIONS: Patients were followed for up to 14 days. Platelet counts were
determined daily. The following data were collected and analyzed as po
tential risk factors for the development of thrombocytopenia: medicati
ons, age, sex, race, trauma score, mode and type of injury, alcohol hi
story, units of packed red blood cells (PRBC) and platelets transfused
, surgical procedures, duration of ICU stay, and the development of sy
stemic inflammatory response syndrome or disseminated intravascular co
agulation. RESULTS: Thrombocytopenia occurred in 26 (41%) of the patie
nts. Among risk factors studied, nonhead injury, age, trauma score, du
ration of ICU stay, and the number of PRBC transfusions were significa
ntly associated with the development of thrombocytopenia (p < 0.05). H
owever, nonhead injury, age, and trauma score were useful variables in
predicting the development of thrombocytopenia by using multivariate
analysis. Medications were not associated with the development of thro
mbocytopenia. CONCLUSIONS: The type of injury sustained, the quantity
of platelet-deficient transfusions, and age are the greatest risk fact
ors associated with the development of thrombocytopenia in critically
ill trauma patients. Drug-induced thrombocytopenia appears to play a m
inor role in the development of thrombocytopenia; therefore, medicatio
ns should not be automatically discontinued or substituted when thromb
ocytopenia occurs.